This Week in PLOS

In PLOS Genetics, researchers from the US, Brazil, and China used a combination of RNA sequencing and chromatin immunoprecipitation sequencing on primary human liver cells to gauge response to metformin, a drug used to treat type 2 diabetes and other conditions.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.